202 related articles for article (PubMed ID: 27447934)
1. miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis.
Seashols-Williams SJ; Budd W; Clark GC; Wu Q; Daniel R; Dragoescu E; Zehner ZE
PLoS One; 2016; 11(7):e0159601. PubMed ID: 27447934
[TBL] [Abstract][Full Text] [Related]
2. Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.
Budd WT; Seashols-Williams SJ; Clark GC; Weaver D; Calvert V; Petricoin E; Dragoescu EA; O'Hanlon K; Zehner ZE
PLoS One; 2015; 10(11):e0142373. PubMed ID: 26544868
[TBL] [Abstract][Full Text] [Related]
3. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection.
Zhang X; Ladd A; Dragoescu E; Budd WT; Ware JL; Zehner ZE
Clin Exp Metastasis; 2009; 26(8):965-79. PubMed ID: 19771525
[TBL] [Abstract][Full Text] [Related]
5. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
6. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels.
Honeywell DR; Cabrita MA; Zhao H; Dimitroulakos J; Addison CL
PLoS One; 2013; 8(8):e70515. PubMed ID: 23950948
[TBL] [Abstract][Full Text] [Related]
7. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
Bhagirath D; Yang TL; Bucay N; Sekhon K; Majid S; Shahryari V; Dahiya R; Tanaka Y; Saini S
Cancer Res; 2018 Apr; 78(7):1833-1844. PubMed ID: 29437039
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
[TBL] [Abstract][Full Text] [Related]
9. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
[TBL] [Abstract][Full Text] [Related]
10. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.
Dhar S; Kumar A; Gomez CR; Akhtar I; Hancock JC; Lage JM; Pound CR; Levenson AS
FEBS Lett; 2017 Mar; 591(6):924-933. PubMed ID: 28231399
[TBL] [Abstract][Full Text] [Related]
11. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
[TBL] [Abstract][Full Text] [Related]
12. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells.
Liu X; Chen Q; Yan J; Wang Y; Zhu C; Chen C; Zhao X; Xu M; Sun Q; Deng R; Zhang H; Qu Y; Huang J; Jiang B; Yu J
Cell Death Dis; 2013 Nov; 4(11):e928. PubMed ID: 24263102
[TBL] [Abstract][Full Text] [Related]
14. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL
PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597
[TBL] [Abstract][Full Text] [Related]
15. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
16. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
[TBL] [Abstract][Full Text] [Related]
17. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
18. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
[TBL] [Abstract][Full Text] [Related]
19. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
20. Treating metastatic prostate cancer with microRNA-145.
Iscaife A; Reis ST; Morais DR; Viana NI; da Silva IA; Pimenta R; Bordini A; Dip N; Srougi M; Leite KRM
Apoptosis; 2018 Aug; 23(7-8):388-395. PubMed ID: 29858716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
